Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $285.56 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $135.66 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $62.02 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $34.34 | 2 | $0 (2024) |
| Lilly USA, LLC | $20.63 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $17.79 | 1 | $0 (2024) |
| Novo Nordisk Inc | $15.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.72 | 8 | AstraZeneca Pharmaceuticals LP ($135.66) |
| 2023 | $51.84 | 3 | GlaxoSmithKline, LLC. ($31.21) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: VACCINES | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Gastroenterology | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Obesity | ||||||
| 05/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 09/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: RESPIRATORY | ||||||
| 08/04/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 305 | 367 | $88,228 | $17,423 |
| 2022 | 6 | 316 | 363 | $87,568 | $17,329 |
| 2021 | 5 | 262 | 309 | $69,439 | $15,059 |
| 2020 | 6 | 286 | 314 | $54,881 | $12,125 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 182 | $51,688 | $8,822 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 86 | $17,200 | $3,763 | 21.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $4,200 | $2,079 | 49.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $13,300 | $1,674 | 12.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,840 | $1,085 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 162 | $46,008 | $7,809 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 121 | $24,200 | $5,491 | 22.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 25 | $3,500 | $1,707 | 48.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 28 | $1,260 | $911.70 | 72.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $7,280 | $724.58 | 10.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $5,320 | $686.02 | 12.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 130 | $36,776 | $7,100 | 19.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 109 | $21,683 | $3,767 | 17.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $6,080 | $1,968 | 32.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $3,640 | $1,697 | 46.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 28 | 28 | $1,260 | $527.24 | 41.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 98 | $23,128 | $4,774 | 20.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 130 | 144 | $23,184 | $4,354 | 18.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 21 | 21 | $2,940 | $1,274 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $4,180 | $1,182 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 27 | 27 | $1,215 | $495.08 | 40.7% |
| 81002 | Urinalysis, manual test | Office | 2020 | 12 | 13 | $234.00 | $45.03 | 19.2% |
About Lyudmila Schowgurow, NURSE PRACTITIONER
Lyudmila Schowgurow, NURSE PRACTITIONER is a Family healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2017. The National Provider Identifier (NPI) number assigned to this provider is 1588173405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lyudmila Schowgurow, NURSE PRACTITIONER has received a total of $285.56 in payments from pharmaceutical and medical device companies, with $233.72 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($285.56).
As a Medicare-enrolled provider, Schowgurow has provided services to 1,169 Medicare beneficiaries, totaling 1,353 services with total Medicare billing of $61,936. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Voorhees, NJ
- Active Since 09/22/2017
- Last Updated 07/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1588173405
Products in Payments
- AIRSUPRA (Drug) $121.83
- XIFAXAN (Drug) $34.34
- AREXVY (Drug) $31.21
- SHINGRIX (Biological) $30.81
- MOUNJARO (Drug) $20.63
- LAGEVRIO (Drug) $17.79
- Wegovy (Drug) $15.12
- FARXIGA (Drug) $13.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Voorhees
Rachelle Coughlin, Np-C, NP-C
Family — Payments: $3,158
Natalie Dwier, Fnp-Bc, FNP-BC
Family — Payments: $2,553
Ms. Taryn Lamorte, Fnp-C, FNP-C
Family — Payments: $2,326
Norma Mann, Apn, APN
Family — Payments: $2,180
Cheri Jackson
Family — Payments: $1,943
Mrs. Margaret Leiter, Apn, APN
Family — Payments: $1,512